Poor glycemic control might compromise the efficacy of chemotherapy in non‐small cell lung cancer patients with diabetes mellitus

BACKGROUND: Previous studies indicated that type 2 diabetes mellitus (T2DM) is related to an increased lung cancer risk, but its role in the prognosis of NSCLC remains conflicting. This study investigated the impact of blood glucose control on the outcomes in NSCLC patients with T2DM treated with pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Xianghua, Xu, Cheng, Cheng, Jianan, Sun, Chengdu, Wang, Zhongyu, Gong, Zhihua, Long, Haixia, Zhu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997083/
https://www.ncbi.nlm.nih.gov/pubmed/31830375
http://dx.doi.org/10.1002/cam4.2750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997083/
https://www.ncbi.nlm.nih.gov/pubmed/31830375
http://dx.doi.org/10.1002/cam4.2750

Ejemplares similares